0.05Open0.05Pre Close0 Volume6 Open Interest0.50Strike Price0.00Turnover2155.18%IV787.10%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.8797Delta0.9185Gamma1.24Leverage Ratio-0.0025Theta0.0000Rho1.09Eff Leverage0.0000Vega
Bright Green Stock Discussion
Bright Green Corporation, a key player in the cultivation and supply of plant-based materials, has announced a strategic partnership with Benuvia Pharmaceuticals. This partnership signifies a major step in the integration of advanced plant-based pharmaceuticals into mainstream medicinal applications. The collabo...
Bright Green Corporation (Nasdaq: BGXX), a company involved in the production, market, and distribution of Schedule I-V plant-based drugs, including opium and cannabis, recently made significant strides in securing financial resources to advance its commercialization efforts. The company has announced the acquisition of a $3.5 million funding commitment under an ex...
No comment yet